A case of corneal cystinosis in a patient with rickets and chronic renal failure.

A 22-year-old man diagnosed with nephropathic cystinosis at the age of 4 years was found to have progressive bilateral corneal crystal deposition. He presented with severe photophobia and decreased visual acuity. Ocular cystinosis was diagnosed on observing the typical crystals. Optical coherence tomography showed multiple areas of stromal hyperreflectivity due to crystal deposits within the corneal stroma. Ex vivo transmission electron microscopy of the cornea showed pathognomonic crystal deposits in corneal stromal keratocytes. Using polymerase chain reaction sequencing of the entire coding region, we identified five gene mutations, including two unreported mutations.

A 22-year-old man diagnosed with nephropathic cystinosis at the age of 4 years was found to have progressive bilateral corneal crystal deposition. Optical coherence tomography (OCT) showed multiple areas of stromal hyper-reflectivity due to crystal deposits, and ex vivo transmission electron microscopy (TEM) of the cornea showed pathognomonic crystal deposits in corneal stromal keratocytes.

Nephropathic cystinosis is a rare autosomal recessive metabolic disorder characterized by a defect in lysosomal cystine transport.[1] Cystinosis is mapped to the CTNS gene on the short arm of chromosome 17 which encodes cystinosin,[2] a 367-amino acid transmembrane protein.[3] The main pathological finding is the intralysosomal accumulation of cystine crystals within most tissues as a result of defective transport.[4] This process eventually causes intracellular crystal deposits in tissues such as the conjunctivae, corneas, kidneys, and bone marrow.[2] The corneal accumulation of needle-shaped cystine crystals is characteristic and progresses from the epithelium toward the endothelium through the stroma of the cornea.[5] There are three main phenotypes of cystinosis: Infantile nephropathic cystinosis, the classic form, accounting for 95% of cases; juvenile cystinosis, the less severe late-onset variant; and adult cystinosis, the benign non-nephropathic form.[2] Cystine transport is retained partially in patients with the intermediate and ocular forms resulting from milder mutations in the CTNS gene.[2]

We present a case of ocular cystinosis confirmed by anterior segment OCT and TEM showing cystine crystals in the cornea, and we identified five mutations, including two unreported ones, using sequencing analysis of the CTNS exon.

Case Report

A 22-year-old man presented with severe photophobia and decreased visual acuity in the right eye. He was diagnosed initially with nephropathic and ocular cystinosis at the age of 4 years. The patient also had chronic renal failure and rickets. The visual acuity was hand motion in the right eye and 4/4 in the left eye. The intraocular pressure was 17 mmHg in the right eye, while that of the left eye could not be measured because the patient was uncooperative. In slit lamp examination, we found the moderate corneal edema and multiple crystal deposits in the right eye and an anterior segment photograph also showed opacity, moderate edema, and multiple progressive refractile polychromatic crystal deposits in the right cornea. Cystagon® (cysteamine bitartrate, Mylan, France) eye drops were prescribed, but there was no improvement in the patient's visual acuity or symptoms. Therefore, we performed penetrating keratoplasty of his right eye. Preoperative anterior segment OCT (Visante, Carl Zeiss Meditec) showed hyperreflectivity at the stroma of the cornea, indicating the presence of corneal cystine crystals [Fig. 1]. Ex vivo light microscopy (LM) of the right cornea performed using special stains for colloidal iron and Masson's trichrome failed to show the crystalline deposits [Fig. 2]. TEM of a corneal biopsy specimen obtained during the operation showed needle-shaped crystalline deposits within keratocytes in corneal stroma of the right eye [Fig. 3]. To examine the genetics of ocular cystinosis, genomic DNA was extracted from peripheral leukocytes using standard protocols. Sequencing analysis identified three known single nucleotide variants (SNVs) and two novel mutations in exon 11 of the CTNS gene [Table 1].

Figure 1

Corneal cystine deposition is observed as optical hyperreflectivity of right anterior one-third (arrow), as shown by cross-sectional anterior segment optical coherence tomography

Figure 2

Ex vivo light microscopy of the right eye (a) Colloidal iron stain, (b) Masson's trichrome stain (Scale bar = 0.5 um)

Figure 3

Electron micrographs of corneal stroma. Crystalline material deposits are a shown in keratocyte of stroma layer (arrow). Note that crystalline deposits are also shown to be membrane-limited at higher magnification (Scale bar = 0.5 um)

Table 1

CTNS gene analysis

Discussion

The typical untreated child with cystinosis has a short stature, light complexion, rickets, and photophobia.[6] Our patient had been diagnosed with rickets and growth failure. We evaluated the status of the cornea using several tools. Anterior segment OCT showed that the anterior one-third of the corneal stoma was hyperreflective, while the posterior two-third was not. The use of TEM to demonstrate the presence of intracellular crystals within corneal keratocytes is a reliable diagnostic tool for cystinosis.[78] In our case, TEM showed square or oblong cystine deposits measuring 0.5–2 μm in length. TEM and anterior segment OCT are useful for ocular cystinosis. These tools are useful in ocular cystinosis cases. Our patient presented with severe photophobia and decreased visual acuity in the right eye. However, ex vivo LM did not show crystalline deposits in the cornea, while ex vivo TEM did show a few such crystalline deposits. Therefore, the degree of symptoms does not correlate with deposits in the cornea, and even a small amount of crystals can cause problems. Topical cysteamine treatment has proven safe and efficient at dissolving corneal crystals in cystinosis patients; it also relieves the symptoms of photophobia, blepharospasm, and ocular pain.[9] Although our patient had used topical cysteamine, he presented with severe photophobia and decreased visual acuity. Therefore, penetrating keratoplasty was performed.

The basic defect involved in cystinosis is impaired transport of cystine across the lysosomal membrane. The gene for cystinosis (CTNS) was mapped to chromosome 17p13 by linkage analysis,[10] and then isolated.[3] This gene contains 12 exons spanning 23 kb of genomic DNA, and exons 3–12 are coding. CTNS mutations result in either the complete abolition of or a reduction in cystine transport.[211] The CTNS gene product, cystinosin, comprises 367 amino acids, seven predicted transmembrane domains, a GY dipeptide for lysosomal targeting near the C-terminus, and eight potential glycosylation sites. Cystinosin has homology with a 55.5-kDa Caenorhabditis elegans protein and the yeast protein ERS1,[12] it facilitates cystine egress from lysosomes. At least 85 different CTNS mutations have been reported in the Human Gene Mutation Database (http://www.hgmd.org/). In cystinosis, the most common CTNS mutation is a 57-kb deletion in which the 3’ border cuts into exon 10.[12] Our patient lacked the 57-kb deletion, but sequencing analysis of all CTNS exons revealed three known SNVs located in intron 6 and exons 7 and 10 in the dbSNP (http://www.ncbi.nlm.nih.gov/snp/) (rs459613, rs200313254, rs161400), and two novel mutations in exon 11 (c. 854C > A, c. 943C > T). Of the two novel gene mutations, one (c. 943C > T) resulted in an amino acid substitution (p.Gln315X), and the other (c. 854C > A) likely affected splicing during transcription because of its location near a predicted acceptor splice site,[13] which would result in an abnormal splicing.

As demonstrated in our patient, TEM and anterior segment OCT are useful to make a diagnosis of ocular cystinosis. Additional gene analysis using complementary DNA may confirm the function of the novel gene.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.